Pharmacologic manipulation of ob expression in a dietary model of obesity (Q38358885)

2 September 2017

Pharmacologic manipulation of ob expression in a dietary model of obesity (English)

1 reference

2 September 2017

0 references

S Collins

1

1 reference

PubMed ID

8621612

2 September 2017

R S Surwit

series ordinal

2

1 reference

PubMed ID

8621612

2 September 2017

language of work or name

English

0 references

publication date

1 April 1996

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

2 September 2017

271

1 reference

2 September 2017

16

1 reference

2 September 2017

9437-9440

1 reference

Positional cloning of the mouse obese gene and its human homologue

2 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Effects of the obese gene product on body weight regulation in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Diet-induced type II diabetes in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]-amino] propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent beta-adrenergic agonist virtually specific for beta 3 receptors. A promising antidiabetic and antiobesity agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Cloning of rat obese cDNA and its expression in obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

In search of a satiety factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

Atypical β-adrenoceptor on brown adipocytes as target for anti-obesity drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.16.9437

21 January 2018

Identifiers

DOI

10.1074/JBC.271.16.9437

1 reference

2 September 2017

1 reference

PubMed ID

8621612